Integra LifeSciences Corp., Healthpoint Ltd. deal

IART sold its Panafil line of healing and debriding agents to treat acute and chronic wounds to Healthpoint for $6.4 million in cash. Under the agreement, IART will receive the first $3 million of Pan...